Scholarly Index
Neal K. Lakdawala
Bristol-Myers Squibb (United States); 10,867 total citations; 207 total publications; best world rank #33
Bristol-Myers Squibb (United States)
10,867Total citations
207Total publications
49H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cardiomyopathy and Myosin Studies | Lifetime | 337 | US 177 | 98.11 |
| Cardiovascular Effects of Exercise | Lifetime | 390 | US 175 | 97.76 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 33 | US 13 | 98.75 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 532 | US 193 | 96.47 |
| Cardiovascular Effects of Exercise | 2021-2025 | 179 | US 57 | 95.28 |
| Viral Infections and Immunology Research | 2021-2025 | 698 | US 184 | 85.07 |
| Nuclear Structure and Function | 2021-2025 | 243 | US 93 | 74.32 |
| Congenital heart defects research | 2021-2025 | 871 | US 333 | 71.94 |
| Innovation Policy and R&D | 2021-2025 | 986 | US 109 | 29.09 |